APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Plasma

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Blood Plasma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025182 pages

Choose your research edition.

Industry ResearchBlood Plasma Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Plasma Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Blood Plasma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Plasma Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Plasma Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Blood Plasma market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Blood Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blood Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Blood Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Blood Plasma include Shanghai Raas, Baxter International, TCS Biosciences, Sanquin, Octapharma, Grifols, CSL, Cerus Corp and ADMA Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Blood Plasma market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood Plasma and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Plasma sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Blood Plasma market size, projected growth trends, production technologies, key applications, and end-use industries.

Blood Plasma Segment by Company

Shanghai Raas

Baxter International

TCS Biosciences

Sanquin

Octapharma

Grifols

CSL

Cerus Corp

ADMA Biologics

Blood Plasma Segment by Type

Protease Inhibitors

Coagulation Factor Concentrates

Immunoglobulin

Albumin

Others

Blood Plasma Segment by Application

Hospitals and Clinics

Research Laboratories

Academic Institutions

Blood Plasma Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Plasma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Plasma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Plasma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Blood Plasma market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Blood Plasma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Blood Plasma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Blood Plasma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Blood Plasma Industry Trends Table 2. Blood Plasma Industry Drivers Table 3. Blood Plasma Industry Opportunities and Challenges Table 4. Blood Plasma Industry Restraints Table 5. Global Blood Plasma Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Blood Plasma Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Blood Plasma Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Blood Plasma Sales Market Share by Manufacturers Table 9. Global Blood Plasma Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Blood Plasma Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Blood Plasma Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Blood Plasma Manufacturers, Product Type & Application Table 13. Global Blood Plasma Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Blood Plasma by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Protease Inhibitors Table 17. Major Manufacturers of Coagulation Factor Concentrates Table 18. Major Manufacturers of Immunoglobulin Table 19. Major Manufacturers of Albumin Table 20. Major Manufacturers of Others Table 21. Global Blood Plasma Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Blood Plasma Sales by Type (2021-2026) & (k units) Table 23. Global Blood Plasma Sales by Type (2027-2032) & (k units) Table 24. Global Blood Plasma Sales Market Share by Type (2021-2026) Table 25. Global Blood Plasma Sales Market Share by Type (2027-2032) Table 26. Global Blood Plasma Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Blood Plasma Revenue by Type (2021-2026) & (k units) Table 28. Global Blood Plasma Revenue by Type (2027-2032) & (k units) Table 29. Global Blood Plasma Revenue Market Share by Type (2021-2026) Table 30. Global Blood Plasma Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospitals and Clinics Table 32. Major Manufacturers of Research Laboratories Table 33. Major Manufacturers of Academic Institutions Table 34. Global Blood Plasma Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Blood Plasma Sales by Application (2021-2026) & (k units) Table 36. Global Blood Plasma Sales by Application (2027-2032) & (k units) Table 37. Global Blood Plasma Sales Market Share by Application (2021-2026) Table 38. Global Blood Plasma Sales Market Share by Application (2027-2032) Table 39. Global Blood Plasma Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Blood Plasma Revenue by Application (2021-2026) & (k units) Table 41. Global Blood Plasma Revenue by Application (2027-2032) & (k units) Table 42. Global Blood Plasma Revenue Market Share by Application (2021-2026) Table 43. Global Blood Plasma Revenue Market Share by Application (2027-2032) Table 44. Global Blood Plasma Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Blood Plasma Sales by Region (2021-2026) & (k units) Table 46. Global Blood Plasma Sales Market Share by Region (2021-2026) Table 47. Global Blood Plasma Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Blood Plasma Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Blood Plasma Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Blood Plasma Sales by Country (2021-2026) & (k units) Table 51. North America Blood Plasma Sales by Country (2027-2032) & (k units) Table 52. Europe Blood Plasma Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Blood Plasma Sales by Country (2021-2026) & (k units) Table 54. Europe Blood Plasma Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Blood Plasma Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Blood Plasma Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Blood Plasma Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Blood Plasma Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Blood Plasma Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Blood Plasma Sales by Country (2027-2032) & (k units) Table 61. Global Blood Plasma Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Blood Plasma Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Blood Plasma Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Blood Plasma Revenue Market Share by Region (2021-2026) Table 65. Global Blood Plasma Revenue Market Share by Region (2027-2032) Table 66. Shanghai Raas Company Information Table 67. Shanghai Raas Business Overview Table 68. Shanghai Raas Blood Plasma Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Shanghai Raas Blood Plasma Product Portfolio Table 70. Shanghai Raas Recent Development Table 71. Baxter International Company Information Table 72. Baxter International Business Overview Table 73. Baxter International Blood Plasma Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Baxter International Blood Plasma Product Portfolio Table 75. Baxter International Recent Development Table 76. TCS Biosciences Company Information Table 77. TCS Biosciences Business Overview Table 78. TCS Biosciences Blood Plasma Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. TCS Biosciences Blood Plasma Product Portfolio Table 80. TCS Biosciences Recent Development Table 81. Sanquin Company Information Table 82. Sanquin Business Overview Table 83. Sanquin Blood Plasma Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sanquin Blood Plasma Product Portfolio Table 85. Sanquin Recent Development Table 86. Octapharma Company Information Table 87. Octapharma Business Overview Table 88. Octapharma Blood Plasma Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Octapharma Blood Plasma Product Portfolio Table 90. Octapharma Recent Development Table 91. Grifols Company Information Table 92. Grifols Business Overview Table 93. Grifols Blood Plasma Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Grifols Blood Plasma Product Portfolio Table 95. Grifols Recent Development Table 96. CSL Company Information Table 97. CSL Business Overview Table 98. CSL Blood Plasma Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. CSL Blood Plasma Product Portfolio Table 100. CSL Recent Development Table 101. Cerus Corp Company Information Table 102. Cerus Corp Business Overview Table 103. Cerus Corp Blood Plasma Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Cerus Corp Blood Plasma Product Portfolio Table 105. Cerus Corp Recent Development Table 106. ADMA Biologics Company Information Table 107. ADMA Biologics Business Overview Table 108. ADMA Biologics Blood Plasma Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. ADMA Biologics Blood Plasma Product Portfolio Table 110. ADMA Biologics Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Blood Plasma Distributors List Table 114. Blood Plasma Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Blood Plasma Product Image Figure 2. Global Blood Plasma Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Plasma Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood Plasma Sales (2021-2032) & (k units) Figure 5. Global Blood Plasma Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Blood Plasma Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Protease Inhibitors Image Figure 9. Coagulation Factor Concentrates Image Figure 10. Immunoglobulin Image Figure 11. Albumin Image Figure 12. Others Image Figure 13. Global Blood Plasma Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Blood Plasma Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Blood Plasma Sales Market Share by Type (2021-2032) Figure 16. Global Blood Plasma Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Blood Plasma Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Blood Plasma Revenue Market Share by Type (2021-2032) Figure 19. Hospitals and Clinics Image Figure 20. Research Laboratories Image Figure 21. Academic Institutions Image Figure 22. Global Blood Plasma Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Blood Plasma Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Blood Plasma Sales Market Share by Application (2021-2032) Figure 25. Global Blood Plasma Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Blood Plasma Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Blood Plasma Revenue Market Share by Application (2021-2032) Figure 28. North America Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Blood Plasma Sales Market Share by Country (2021-2032) Figure 30. U.S. Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Blood Plasma Sales Market Share by Country (2021-2032) Figure 35. Germany Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Blood Plasma Sales Market Share by Country (2021-2032) Figure 42. China Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Blood Plasma Sales Market Share by Country (2021-2032) Figure 50. Brazil Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Blood Plasma Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Blood Plasma Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Blood Plasma Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Blood Plasma Revenue (2021-2032) & (US$ Million) Figure 61. North America Blood Plasma Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Blood Plasma Revenue (2021-2032) & (US$ Million) Figure 63. Europe Blood Plasma Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Blood Plasma Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Blood Plasma Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Blood Plasma Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Blood Plasma Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Blood Plasma Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Blood Plasma Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Protease Inhibitors
  • Coagulation Factor Concentrates
  • Immunoglobulin
  • Albumin
  • Others
Applications
  • Hospitals and Clinics
  • Research Laboratories
  • Academic Institutions
Companies covered
  • Shanghai Raas
  • Baxter International
  • TCS Biosciences
  • Sanquin
  • Octapharma
  • Grifols
  • CSL
  • Cerus Corp
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Blood Plasma Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Blood Plasma Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Blood Plasma Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Blood Plasma Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Blood Plasma Market Dynamics
  1. 2.1 Blood Plasma Industry Trends
  2. 2.2 Blood Plasma Industry Drivers
  3. 2.3 Blood Plasma Industry Opportunities and Challenges
  4. 2.4 Blood Plasma Industry Restraints
3 Blood Plasma Market by Manufacturers
  1. 3.1 Global Blood Plasma Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Blood Plasma Sales by Manufacturers (2021-2026)
  3. 3.3 Global Blood Plasma Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Blood Plasma Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Blood Plasma Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Blood Plasma Manufacturers, Product Type & Application
  7. 3.7 Global Blood Plasma Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Blood Plasma Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Blood Plasma Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Blood Plasma Tier 1, Tier 2, and Tier 3
4 Blood Plasma Market by Type
  1. 4.1 Blood Plasma Type Introduction
  2. 4.1.1 Protease Inhibitors
  3. 4.1.2 Coagulation Factor Concentrates
  4. 4.1.3 Immunoglobulin
  5. 4.1.4 Albumin
  6. 4.1.5 Others
  7. 4.2 Global Blood Plasma Sales by Type
  8. 4.2.1 Global Blood Plasma Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Blood Plasma Sales by Type (2021-2032)
  10. 4.2.3 Global Blood Plasma Sales Market Share by Type (2021-2032)
  11. 4.3 Global Blood Plasma Revenue by Type
  12. 4.3.1 Global Blood Plasma Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Blood Plasma Revenue by Type (2021-2032)
  14. 4.3.3 Global Blood Plasma Revenue Market Share by Type (2021-2032)
5 Blood Plasma Market by Application
  1. 5.1 Blood Plasma Application Introduction
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Research Laboratories
  4. 5.1.3 Academic Institutions
  5. 5.2 Global Blood Plasma Sales by Application
  6. 5.2.1 Global Blood Plasma Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Blood Plasma Sales by Application (2021-2032)
  8. 5.2.3 Global Blood Plasma Sales Market Share by Application (2021-2032)
  9. 5.3 Global Blood Plasma Revenue by Application
  10. 5.3.1 Global Blood Plasma Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Blood Plasma Revenue by Application (2021-2032)
  12. 5.3.3 Global Blood Plasma Revenue Market Share by Application (2021-2032)
6 Global Blood Plasma Sales by Region
  1. 6.1 Global Blood Plasma Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood Plasma Sales by Region (2021-2032)
  3. 6.2.1 Global Blood Plasma Sales by Region (2021-2026)
  4. 6.2.2 Global Blood Plasma Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Blood Plasma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Blood Plasma Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Blood Plasma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Blood Plasma Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Blood Plasma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Blood Plasma Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Blood Plasma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Blood Plasma Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Blood Plasma Revenue by Region
  1. 7.1 Global Blood Plasma Revenue by Region
  2. 7.1.1 Global Blood Plasma Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Blood Plasma Revenue by Region (2021-2026)
  4. 7.1.3 Global Blood Plasma Revenue by Region (2027-2032)
  5. 7.1.4 Global Blood Plasma Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Blood Plasma Revenue (2021-2032)
  8. 7.2.2 North America Blood Plasma Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Blood Plasma Revenue (2021-2032)
  11. 7.3.2 Europe Blood Plasma Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Blood Plasma Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Blood Plasma Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Blood Plasma Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Blood Plasma Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Raas
  2. 8.1.1 Shanghai Raas Company Information
  3. 8.1.2 Shanghai Raas Business Overview
  4. 8.1.3 Shanghai Raas Blood Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Raas Blood Plasma Product Portfolio
  6. 8.1.5 Shanghai Raas Recent Developments
  7. 8.2 Baxter International
  8. 8.2.1 Baxter International Company Information
  9. 8.2.2 Baxter International Business Overview
  10. 8.2.3 Baxter International Blood Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter International Blood Plasma Product Portfolio
  12. 8.2.5 Baxter International Recent Developments
  13. 8.3 TCS Biosciences
  14. 8.3.1 TCS Biosciences Company Information
  15. 8.3.2 TCS Biosciences Business Overview
  16. 8.3.3 TCS Biosciences Blood Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 TCS Biosciences Blood Plasma Product Portfolio
  18. 8.3.5 TCS Biosciences Recent Developments
  19. 8.4 Sanquin
  20. 8.4.1 Sanquin Company Information
  21. 8.4.2 Sanquin Business Overview
  22. 8.4.3 Sanquin Blood Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanquin Blood Plasma Product Portfolio
  24. 8.4.5 Sanquin Recent Developments
  25. 8.5 Octapharma
  26. 8.5.1 Octapharma Company Information
  27. 8.5.2 Octapharma Business Overview
  28. 8.5.3 Octapharma Blood Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Octapharma Blood Plasma Product Portfolio
  30. 8.5.5 Octapharma Recent Developments
  31. 8.6 Grifols
  32. 8.6.1 Grifols Company Information
  33. 8.6.2 Grifols Business Overview
  34. 8.6.3 Grifols Blood Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Grifols Blood Plasma Product Portfolio
  36. 8.6.5 Grifols Recent Developments
  37. 8.7 CSL
  38. 8.7.1 CSL Company Information
  39. 8.7.2 CSL Business Overview
  40. 8.7.3 CSL Blood Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CSL Blood Plasma Product Portfolio
  42. 8.7.5 CSL Recent Developments
  43. 8.8 Cerus Corp
  44. 8.8.1 Cerus Corp Company Information
  45. 8.8.2 Cerus Corp Business Overview
  46. 8.8.3 Cerus Corp Blood Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cerus Corp Blood Plasma Product Portfolio
  48. 8.8.5 Cerus Corp Recent Developments
  49. 8.9 ADMA Biologics
  50. 8.9.1 ADMA Biologics Company Information
  51. 8.9.2 ADMA Biologics Business Overview
  52. 8.9.3 ADMA Biologics Blood Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ADMA Biologics Blood Plasma Product Portfolio
  54. 8.9.5 ADMA Biologics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Blood Plasma Value Chain Analysis
  2. 9.1.1 Blood Plasma Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Blood Plasma Production Mode & Process
  6. 9.2 Blood Plasma Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Blood Plasma Distributors
  9. 9.2.3 Blood Plasma Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst